Cancer Epigenetics and Nanomedicine

Targeting the Right Player Via Nanotechnology
Erscheinungsjahr 2024
ISBN: 978-0-443-13209-4
Verlag: Elsevier Science

Buch, Englisch, 458 Seiten, Format (B × H): 192 mm x 234 mm, Gewicht: 950 g

Cancer Epigenetics and Nanomedicine: Targeting the Right Player via Nanotechnology is a complete package that provides a comprehensive and thorough understanding of the key players that modulate the various steps of carcinogenesis and malignant progression of the disease and the critical targets to be exploited for developing novel modalities of diagnosis and therapeutics.

Since epigenetic aberrations can be potentially reversed and restored to their normal state through epigenetic therapy, the book also discusses the challenges and the future of the field with the cutting-edge revelations and limitations that this research endeavor can offer, thereby helping the readers to enhance their critical thinking and adopt strategies of therapeutic importance.

Autoren/Hrsg.

Kesharwani, Prashant

Fachgebiete

• Wirtschaftswissenschaften Betriebswirtschaft Unternehmensforschung
• Mathematik | Informatik EDV | Informatik Business Application Unternehmenssoftware

Inhaltsverzeichnis

SECTION 1 Overview of cancer, internal and external factors associated with cancer
1. Overview of cancer: Mechanisms of carcinogenesis
2. Tumor metabolism and micronutrients: New insights to target malignant tumors
3. The role of one-carbon amino acids in tumor-immune metabolism: From oncogenesis to therapy
4. Environmental causes of cancer
5. Cancer stem cells—Challenges for cancer therapies
6. Carving a therapeutic niche for metastatic cancer: Opportunities and challenges

SECTION 2 Epigenetics and its importance in cancer therapies
7. An overview of epigenetics and cancer
8. Metabolic adaptation and epigenetic modulations: Unraveling tumor plasticity under variable tumor microenvironment
9. Involvement of epigenetic modifications in cancer stem cells and chemoresistance
10. Cancer biomarkers: Where genetics meets epigenetics
11. Epigenetics approach in cancer treatment with focus on lung and breast cancer
12. Dietary components as epigenetic modifiers and their roles in cancer prevention

SECTION 3 Nanomedicine targeting epigenetic machinery in cancer therapy
13. Harnessing plant-derived biosynthetic nanomaterials for epigenetic modulation in cancer therapy
14. Nanotechnology-enhanced immunotherapy for cancer
15. Nanoparticles in metastatic cancer treatment
16. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer
17. Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives
18. Smart cancer nanomedicine: Challenges and future opportunities

Über Autor(innen)

Kesharwani, Prashant
Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. He has over 12 years of teaching and research experience, specializing in translational nanomedicine, polymeric biomaterials, targeted drug delivery, and nanoengineered drug delivery systems. He has authored more than 400 peer-reviewed publications in reputed international journals and edited over 30 international books. His research has received widespread recognition, with an h-index exceeding 100. He has secured several competitive research grants from national funding agencies and received prestigious honors, including the USERN Laureate Award and the SERB–Ramanujan Fellowship. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and translational pharmaceutical research. He actively contributes to academic mentoring, scientific research, and scholarly publishing.